These articles have been peer reviewed by the members of the Scientific Committee and approved by the Editor-in-Chief, who affirms that this document is a truthful description of the conference's review process. Review ProcedureThe reviews were open. Each submission was examined by 2 reviewers independently.The conference submission management system was REMIT on https://icb-pharma. ums.ac.id/2021/ The submissions were first screened for generic quality and suitableness. Authors choose directly the track that suitable with their articles. The track director then did the initial screening, and sent the article for peer review by matching each article's topic with the reviewers' expertise, taking into account any competing interests. An article could only be considered for acceptance if it had received favourable recommendations from the two reviewers.Authors of a rejected submission were given the opportunity to revise and resubmit after addressing the reviewers' comments. The acceptance or rejection of a revised manuscript was final. Quality CriteriaReviewers were instructed to assess the quality of submissions solely based on the academic merit of their content along the following dimensions:1. Originality and level of innovativeness; 2. Thematic relevance for the call for papers; 3. Significance for theory or practice; 4. Methodology well discussed (Experimental planning and preparation); 5. Quality of Presentation of tables and figures. 6. Conclusion supported by results of work and future work.In addition, all of the articles have been checked for textual overlap in an effort to detect possible signs of plagiarism by the publisher. Turnitin was used to detect the plagiarism.